Identifying Breast Cancer Risk in Patients Undergoing Gender‐Affirming Chest Masculinization Surgery
Journal of Surgical Oncology · 2026-07 · 134 (1) · 25-30
DOI: 10.1002/jso.70272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 23.04.2026. Verfasst von Jamie E Cronin und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Colorado Anschutz School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Early Detection of Cancer, Gender-Affirming Surgery, Mastectomy. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Objectives Breast cancer risk among transgender and gender‐diverse individuals undergoing gender‐affirming chest masculinization (“top”) surgery remains poorly defined. This study aimed to characterize breast cancer risk and management in this population.
Methods
We conducted retrospective chart review of patients undergoing top surgery within an academic plastic surgery practice. Variables included family and reproductive history, genetic testing, International Breast Intervention Study (IBIS) scores, and final pathology. The primary outcome was elevated breast cancer risk, defined as IBIS ≥ 20% (high risk) or 15%–19% (intermediate). Significance was set at p < 0.05.
Results
From April 2019 to December 2024, 284 individuals underwent top surgery. One‐third reported a family history of breast cancer, and two of fifteen genetically tested patients carried pathogenic variants. IBIS scores were calculable in 79 patients, with 43% demonstrating intermediate or high risk (IBIS ≥ 15%). Seven patients were referred to breast surgical oncology and fifteen to genetics; four high‐risk individuals elected risk‐reducing mastectomy. One case of ductal carcinoma in situ was identified during risk‐reducing mastectomy.
Conclusion
A subset of top surgery patients exhibit elevated familial, genetic, or IBIS‐based breast cancer risk. Although incidental malignancy was rare, structured risk assessment and selective referral may improve screening and management in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Colorado Anschutz School of Medicine, Aurora, Colorado, USA.
- Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Coloado, USA.
- Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- UCHealth Hereditary Cancer Clinic, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- UCHealth Diane O'Connor Thompson Breast Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Zain Aryanpour
Zitieren
APA
Cronin, J. E., Aryanpour, Z., Durden, J. A., Hunt, S. C., Arkema, A., Christian, N. T., Kaoutzanis, C., Mathes, D. W., Egan, K. G., & Tevis, S. E. (2026). Identifying Breast Cancer Risk in Patients Undergoing Gender‐Affirming Chest Masculinization Surgery. Journal of Surgical Oncology, 134(1), 25-30. https://doi.org/10.1002/jso.70272
Vancouver
Cronin JE, Aryanpour Z, Durden JA, Hunt SC, Arkema A, Christian NT, et al. Identifying Breast Cancer Risk in Patients Undergoing Gender‐Affirming Chest Masculinization Surgery. Journal of Surgical Oncology. 2026;134(1):25-30. doi:10.1002/jso.70272
BibTeX
@article{Cronin2026,
author = {Cronin, Jamie E and Aryanpour, Zain and Durden, Jakob A and Hunt, Sarah C and Arkema, Ashley and Christian, Nicole T and Kaoutzanis, Christodoulos and Mathes, David W and Egan, Katie G and Tevis, Sarah E},
title = {Identifying Breast Cancer Risk in Patients Undergoing Gender‐Affirming Chest Masculinization Surgery},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {134},
number = {1},
pages = {25--30},
doi = {10.1002/jso.70272}
}
EUVIMED